vs
ADMA BIOLOGICS, INC.（ADMA）与RCI HOSPITALITY HOLDINGS, INC.（RICK）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是RCI HOSPITALITY HOLDINGS, INC.的2.0倍（$139.2M vs $70.9M），ADMA BIOLOGICS, INC.净利率更高（35.5% vs -7.8%，领先43.2%），ADMA BIOLOGICS, INC.同比增速更快（18.4% vs -3.1%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $11.5M），过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs -2.0%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
RCI Hospitality控股通过子公司经营脱衣舞俱乐部、夜总会、运动酒吧与餐厅，同时还运营一家为成人俱乐部行业提供服务的传媒会展企业。公司于1995年完成首次公开募股上市，目前在纳斯达克全球市场挂牌交易。
ADMA vs RICK — 直观对比
营收规模更大
ADMA
是对方的2.0倍
$70.9M
营收增速更快
ADMA
高出21.5%
-3.1%
净利率更高
ADMA
高出43.2%
-7.8%
自由现金流更多
ADMA
多$23.1M
$11.5M
两年增速更快
ADMA
近两年复合增速
-2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $70.9M |
| 净利润 | $49.4M | $-5.5M |
| 毛利率 | 63.8% | — |
| 营业利润率 | 45.1% | -0.7% |
| 净利率 | 35.5% | -7.8% |
| 营收同比 | 18.4% | -3.1% |
| 净利润同比 | -55.9% | -2354.9% |
| 每股收益（稀释后） | $0.20 | $-0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMARICK
| Q4 25 | $139.2M | — | ||
| Q3 25 | $134.2M | $70.9M | ||
| Q2 25 | $122.0M | $71.1M | ||
| Q1 25 | $114.8M | $65.9M | ||
| Q4 24 | $117.5M | $71.5M | ||
| Q3 24 | $119.8M | $73.2M | ||
| Q2 24 | $107.2M | $76.2M | ||
| Q1 24 | $81.9M | $72.3M |
净利润ADMARICK
| Q4 25 | $49.4M | — | ||
| Q3 25 | $36.4M | $-5.5M | ||
| Q2 25 | $34.2M | $4.1M | ||
| Q1 25 | $26.9M | $3.2M | ||
| Q4 24 | $111.9M | $9.0M | ||
| Q3 24 | $35.9M | $244.0K | ||
| Q2 24 | $32.1M | $-5.2M | ||
| Q1 24 | $17.8M | $774.0K |
毛利率ADMARICK
| Q4 25 | 63.8% | — | ||
| Q3 25 | 56.3% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 53.2% | — | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 49.8% | — | ||
| Q2 24 | 53.6% | — | ||
| Q1 24 | 47.8% | — |
营业利润率ADMARICK
| Q4 25 | 45.1% | — | ||
| Q3 25 | 38.0% | -0.7% | ||
| Q2 25 | 35.1% | 12.2% | ||
| Q1 25 | 30.4% | 12.4% | ||
| Q4 24 | 32.6% | 19.5% | ||
| Q3 24 | 33.1% | 4.8% | ||
| Q2 24 | 36.6% | -3.3% | ||
| Q1 24 | 26.7% | 6.4% |
净利率ADMARICK
| Q4 25 | 35.5% | — | ||
| Q3 25 | 27.1% | -7.8% | ||
| Q2 25 | 28.1% | 5.7% | ||
| Q1 25 | 23.4% | 4.9% | ||
| Q4 24 | 95.2% | 12.6% | ||
| Q3 24 | 30.0% | 0.3% | ||
| Q2 24 | 29.9% | -6.9% | ||
| Q1 24 | 21.7% | 1.1% |
每股收益（稀释后）ADMARICK
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.15 | $-0.60 | ||
| Q2 25 | $0.14 | $0.46 | ||
| Q1 25 | $0.11 | $0.36 | ||
| Q4 24 | $0.45 | $1.01 | ||
| Q3 24 | $0.15 | $0.04 | ||
| Q2 24 | $0.13 | $-0.56 | ||
| Q1 24 | $0.08 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $33.7M |
| 总债务越低越好 | $72.1M | $238.2M |
| 股东权益账面价值 | $477.3M | $261.1M |
| 总资产 | $624.2M | $596.9M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.91× |
8季度趋势，按日历期对齐
现金及短期投资ADMARICK
| Q4 25 | $87.6M | — | ||
| Q3 25 | $61.4M | $33.7M | ||
| Q2 25 | $90.3M | $29.3M | ||
| Q1 25 | $71.6M | $32.7M | ||
| Q4 24 | $103.1M | $34.7M | ||
| Q3 24 | $86.7M | $32.4M | ||
| Q2 24 | $88.2M | $34.9M | ||
| Q1 24 | $45.3M | $20.0M |
总债务ADMARICK
| Q4 25 | $72.1M | — | ||
| Q3 25 | $72.4M | $238.2M | ||
| Q2 25 | — | $243.8M | ||
| Q1 25 | — | $244.1M | ||
| Q4 24 | $72.3M | — | ||
| Q3 24 | — | $241.1M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADMARICK
| Q4 25 | $477.3M | — | ||
| Q3 25 | $431.2M | $261.1M | ||
| Q2 25 | $398.3M | $269.5M | ||
| Q1 25 | $373.4M | $268.8M | ||
| Q4 24 | $349.0M | $269.0M | ||
| Q3 24 | $231.9M | $263.4M | ||
| Q2 24 | $188.3M | $271.2M | ||
| Q1 24 | $153.7M | $285.8M |
总资产ADMARICK
| Q4 25 | $624.2M | — | ||
| Q3 25 | $568.7M | $596.9M | ||
| Q2 25 | $558.4M | $597.4M | ||
| Q1 25 | $510.6M | $589.8M | ||
| Q4 24 | $488.7M | $586.2M | ||
| Q3 24 | $390.6M | $584.4M | ||
| Q2 24 | $376.4M | $601.0M | ||
| Q1 24 | $350.9M | $609.9M |
负债/权益比ADMARICK
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | 0.91× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.91× | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | — | 0.92× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $13.7M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $11.5M |
| 自由现金流率自由现金流/营收 | 24.8% | 16.2% |
| 资本支出强度资本支出/营收 | 0.8% | 3.2% |
| 现金转化率经营现金流/净利润 | 0.72× | — |
| 过去12个月自由现金流最近4个季度 | $27.8M | $34.9M |
8季度趋势，按日历期对齐
经营现金流ADMARICK
| Q4 25 | $35.6M | — | ||
| Q3 25 | $13.3M | $13.7M | ||
| Q2 25 | $21.1M | $13.8M | ||
| Q1 25 | $-19.7M | $8.5M | ||
| Q4 24 | $50.2M | $13.3M | ||
| Q3 24 | $25.0M | $15.7M | ||
| Q2 24 | $45.6M | $15.8M | ||
| Q1 24 | $-2.2M | $10.8M |
自由现金流ADMARICK
| Q4 25 | $34.6M | — | ||
| Q3 25 | $-1.1M | $11.5M | ||
| Q2 25 | $18.7M | $10.1M | ||
| Q1 25 | $-24.4M | $5.7M | ||
| Q4 24 | $47.5M | $7.6M | ||
| Q3 24 | $24.0M | $10.3M | ||
| Q2 24 | $43.6M | $9.3M | ||
| Q1 24 | $-4.6M | $3.2M |
自由现金流率ADMARICK
| Q4 25 | 24.8% | — | ||
| Q3 25 | -0.8% | 16.2% | ||
| Q2 25 | 15.3% | 14.2% | ||
| Q1 25 | -21.2% | 8.6% | ||
| Q4 24 | 40.4% | 10.6% | ||
| Q3 24 | 20.0% | 14.0% | ||
| Q2 24 | 40.7% | 12.3% | ||
| Q1 24 | -5.6% | 4.4% |
资本支出强度ADMARICK
| Q4 25 | 0.8% | — | ||
| Q3 25 | 10.7% | 3.2% | ||
| Q2 25 | 2.0% | 5.2% | ||
| Q1 25 | 4.1% | 4.3% | ||
| Q4 24 | 2.3% | 8.0% | ||
| Q3 24 | 0.9% | 7.3% | ||
| Q2 24 | 1.9% | 8.4% | ||
| Q1 24 | 2.9% | 10.6% |
现金转化率ADMARICK
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | 0.62× | 3.40× | ||
| Q1 25 | -0.73× | 2.65× | ||
| Q4 24 | 0.45× | 1.48× | ||
| Q3 24 | 0.70× | 64.14× | ||
| Q2 24 | 1.42× | — | ||
| Q1 24 | -0.12× | 14.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
RICK
| Transferred At Point In Time | $60.8M | 86% |
| Food And Merchandise | $10.4M | 15% |
